Europe PMC requires Javascript to function effectively.
Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please
turn on Javascript support in your web browser and reload this page.
Table 3
Characteristics of participants with the rs8099917 TT and GT/GG genotypes among those with available genotype testing.
| Characteristic | Overall (n=102) | GG/GT (n=39) | % | TT (n=63) | % |
|---|
| Sex | | | | | |
| Male | 74 | 29 | 74% | 45 | 71% |
| Female | 28 | 10 | 26% | 18 | 29% |
| Ethnicity | | | | | |
| Caucasian | 92 | 34 | 87% | 58 | 92% |
| Other | 10 | 5 | 13% | 5 | 8% |
| Presentation of recent HCV | | | | | |
| Asymptomatic seroconversion | 55 | 27 | 69% | 28 | 44% |
| Acute clinical (no jaundice) | 23 | 9 | 23% | 14 | 22% |
| Acute clinical (with jaundice) | 22 | 2 | 5% | 20 | 32% |
| Peak ALT prior to enrolment (IU/L) | | | | | |
| ≤ 400 | 37 | 21 | 54% | 16 | 25% |
| > 400 | 60 | 15 | 38% | 45 | 71% |